Serum amyloid P inhibits granulocyte adhesion

Fibrogenesis and Tissue Repair

Volumn 6, Issue 1, 2013, Pages

  Maharjan, Anu S ^a,b   Roife, David ^a   Brazill, Derrick ^c   Gomer, Richard H ^b  

^a RICE UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Acute respiratory distress syndrome; Adhesion; ALI; ARDS; Neutrophil; Serum amyloid P

Indexed keywords

BLEOMYCIN; CD11B ANTIGEN; CD18 ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HERMES ANTIGEN; HYDROGEN PEROXIDE; L SELECTIN; LYSINE; SERUM AMYLOID P;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GRANULOCYTE; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKOCYTE ADHERENCE INHIBITION; LEUKOCYTE METABOLISM; LEUKOCYTE MIGRATION INHIBITION; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FUNCTION;

EID: 84876391688     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-6-2     Document Type: Article

References (83)

1. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7:678-689. 10.1038/nri2156, 17717539.
2. Soehnlein O, Lindbom L, Weber C. Mechanisms underlying neutrophil-mediated monocyte recruitment. Blood 2009, 114:4613-4623. 10.1182/blood-2009-06-221630, 19696199.
3. Edwards SW. Biochemistry and Physiology of the Neutrophil 1994, 299. Cambridge, UK: Cambridge University Press.
4. Kuntz RM, Saltzman WM. Neutrophil motility in extracellular matrix gels: mesh size and adhesion affect speed of migration. Biophys 1997, 72:1472-1480.
5. Hidalgo A, Peired AJ, Wild MK, Vestweber D, Frenette PS. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 2007, 26:477-489. 10.1016/j.immuni.2007.03.011, 17442598.
6. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994, 84:2068-2101.
7. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994, 8:504-512.
8. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol 2001, 153:1277-1286. 10.1083/jcb.153.6.1277, 2192031, 11402070.
9. Cassatella MA. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999, 73:369-509.
10. Montecucco F, Steffens S, Burger F, Da Costa A, Bianchi G, Bertolotto M, Mach F, Dallegri F, Ottonello L. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways. Cell Signal 2008, 20:557-568. 10.1016/j.cellsig.2007.11.008, 18164590.
11. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987, 80:1550-1560. 10.1172/JCI113241, 442423, 2445780.
12. Weisbart RH, Golde DW, Clark SC, Wong GG, Gasson JC. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature 1985, 314:361-363. 10.1038/314361a0, 2984574.
13. Yong KL, Linch DC. Differential effects of granulocyte- and granulocyte-macrophage colony-stimulating factors (G- and GM-CSF) on neutrophil adhesion in vitro and in vivo. Eur J Haematol 1992, 49:251-259.
14. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 1992, 13:93-100. 10.1016/0167-5699(92)90149-2, 1377920.
15. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000, 80:617-653. 10.1038/labinvest.3780067, 10830774.
16. Leonard EJ, Yoshimura T. Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]). Am J Res Cell Mol Biol 1990, 2:479-486.
17. Drost EM, MacNee W. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur J Immunol 2002, 32:393-403. 10.1002/1521-4141(200202)32:2<393::AID-IMMU393>3.0.CO;2-5, 11813158.
18. Frank RS. Time-dependent alterations in the deformability of human neutrophils in response to chemotactic activation. Blood 1990, 76:2606-2612.
19. Norgauer J, Krutmann J, Dobos GJ, Traynor-Kaplan AE, Oades ZG, Schraufstätter IU. Actin polymerization, calcium-transients, and phospholipid metabolism in human neutrophils after stimulation with interleukin-8 and N-formyl peptide. J Invest Derma 1994, 102:310-314.
20. Crossley LJ. Neutrophil activation by fMLP regulates FOXO (forkhead) transcription factors by multiple pathways, one of which includes the binding of FOXO to the survival factor Mcl-1. J Leukoc Biol 2003, 74:583-592. 10.1189/jlb.0103020, 12960271.
21. Strieter RM, Kasahara K, Allen RM, Standiford TJ, Rolfe MW, Becker FS, Chensue SW, Kunkel SL. Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 1992, 141:397-407. 1886610, 1497091.
22. Hughes SF, Cotter MJ, Evans SA, Jones KP, Adams RA. The role of leukocytes in damage to the vascular endothelium during ischaemia-reperfusion injury. Br J Biomed Sci 2006, 63:166-170.
23. Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001, 7:1-7. 10.1097/00075198-200102000-00001, 11373504.
24. Wertheim WA, Kunkel SL, Standiford TJ, Burdick MD, Becker FS, Wilke CA, Gilbert AR, Strieter RM. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J Immunol 1993, 151:2166-2175.
25. Tryzmel J, Miskolci V, Castro-Alcaraz S, Vancurova I, Davidson D. Interleukin-10 inhibits proinflammatory chemokine release by neutrophils of the newborn without suppression of nuclear factor-kappa B. Pediat Res 2003, 54:382-386. 10.1203/01.PDR.0000077471.36217.6E, 12788980.
26. Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 1993, 151:5666-5674.
27. Shanley TP, Vasi N, Denenberg A. Regulation of chemokine expression by IL-10 in lung inflammation. Cytokine 2000, 12:1054-1064. 10.1006/cyto.1999.0655, 10880252.
28. Papayianni A, Serhan CN, Brady HR. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J Immunol 1996, 156:2264-2272.
29. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Ann Rev Immunol 2007, 25:101-137.
30. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8:349-361. 10.1038/nri2294, 2744593, 18437155.
31. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002, 196:1025-1037. 10.1084/jem.20020760, 2194036, 12391014.
32. Deban L, Russo RC, Sironi M, Moalli F, Scanziani M, Zambelli V, Cuccovillo I, Bastone A, Gobbi M, Valentino S, Doni A, Garlanda C, Danese S, Salvatori G, Sassano M, Evangelista V, Rossi B, Zenaro E, Constantin G, Laudanna C, Bottazzi B, Mantovani A. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 2010, 11:328-334. 10.1038/ni.1854, 20208538.
33. El Kebir D, Zhang Y, Potempa LA, Wu Y, Fournier A, Filep JG. C-reactive protein-derived peptide 201-206 inhibits neutrophil adhesion to endothelial cells and platelets through CD32. J Leuk Biol 2011, 90:1167-1175.
34. Han B, Haitsma JJ, Zhang Y, Bai X, Rubacha M, Keshavjee S, Zhang H, Liu M. Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury. Int Care Med 2011, 37:334-342.
35. Heuertz RM, Piquette CA, Webster RO. Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am J Pathol 1993, 142:319-328. 1886843, 8424463.
36. Heuertz RM, Tricomi SM, Ezekiel UR, Webster RO. C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement. J Biol Chem 1999, 274:17968-17974. 10.1074/jbc.274.25.17968, 10364245.
37. Heuertz RM, Webster RO. Role of C-reactive protein in acute lung injury. Mol Med Today 1997, 3:539-545. 10.1016/S1357-4310(97)01145-3, 9449125.
38. Savchenko AS, Inoue A, Ohashi R, Jiang S, Hasegawa G, Tanaka T, Hamakubo T, Kodama T, Aoyagi Y, Ushiki T, Naito M. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis. Path Intern 2011, 61:290-297.
39. Baudino L, Nimmerjahn F, Azeredo-da-Silveira S, Martinez-Soria E, Saito T, Carroll M, Ravetch JV, Verbeek JS, Izui S. Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice. J Immunol 2008, 180:1948-1953.
40. Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008, 8:34-47. 10.1038/nri2206, 18064051.
41. Goulding NJ, Knight SM, Godolphin JL, Guyre PM. Increase in neutrophil Fc gamma receptor I expression following interferon gamma treatment in rheumatoid arthritis. Ann Rheum Dis 1992, 51:465-468. 10.1136/ard.51.4.465, 1004692, 1534001.
42. Nimmerjahn F, Ravetch JV. Analyzing antibody-Fc-receptor interactions. Meth Mol Biol 2008, 415:151-162.
43. Tsuboi N, Asano K, Lauterbach M, Mayadas TN. Human neutrophil Fc3 receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity 2008, 28:833-846. 10.1016/j.immuni.2008.04.013, 2577844, 18538590.
44. Bharadwaj D, Mold C, Markham E, Du Clos TW. Serum amyloid P component binds to Fcgamma receptors and opsonizes particles for phagocytosis. J Immunol 2001, 166:6735-6741.
45. Mold C, Baca R, Du Clos TW. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors. J Autoimmun 2002, 19:147-154. 10.1006/jaut.2002.0615, 12419285.
46. Mold C, Gresham HD, Du Clos TW. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs. J Immunol 2001, 166:1200-1205.
47. Moalli F, Jaillon S, Inforzato A, Sironi M, Bottazzi B, Mantovani A, Garlanda C. Pathogen recognition by the long pentraxin PTX3. J Biomed Biotechnol 2011, 2011:830421. 3118294, 21716666.
48. Nelson SR, Tennent GA, Sethi D, Gower PE, Ballardie FW, Amatayakul-Chantler S, Pepys MB. Serum amyloid P component in chronic renal failure and dialysis. Intern J Clin Chem 1991, 200:191-199.
49. Mortensen RF, Beisel K, Zeleznik NJ, Le PT. Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation. J Immunol 1983, 130:885-889.
50. Pilling D, Buckley CD, Salmon M, Gomer RH. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 2003, 171:5537-5546.
51. Crawford JR, Pilling D, Gomer RH. FcgammaRI mediates serum amyloid P inhibition of fibrocyte differentiation. J Leuk Biol 2012, 92:699-711.
52. Pilling D, Roife D, Wang M, Ronkainen SD, Crawford JR, Travis EL, Gomer RH. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 2007, 179:4035-4044.
53. Castaño AP, Lin SL, Surowy T, Nowlin BT, Turlapati SA, Patel T, Singh A, Li S, Lupher ML, Duffield JS. Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo. Sci Transl Med 2009, 5ra13.
54. Pepys MB, Gallimore JR, Lloyd J, Li Z, Graham D, Taylor GW, Ellmerich S, Mangione PP, Tennent GA, Hutchinson WL, Millar DJ, Bennett G, More J, Evans D, Mistry Y, Poole S, Hawkins PN. Isolation and characterization of pharmaceutical grade human pentraxin, serum amyloid P component and C-reactive protein, for clinical use. J Immunol Meth 2012, 384:92-102.
55. Waddell TK, Fialkow L, Chan CK, Kishimoto TK, Downey GP. Potentiation of the oxidative burst of human neutrophils. A signaling role for L-selectin. J Biol Chem 1994, 269:18485-18491.
56. Polevshchikov AV, Nazarov PG, Kozlov SV, Galkina EV, Berestova LK. The regulation of blood neutrophil functions by C-reactive protein and serum amyloid P. Fiziologicheskii zhurnal imeni IM Sechenova/Rossiiskaia akademiia nauk 1996, 82:67-72.
57. Timoshenko AV, Bovin NV, Shiyan SD, Vakhrushev SY, André S, Gabius HJ. Modification of the functional activity of neutrophils treated with acute phase response proteins. Bioch Biokhimiia 1998, 63:546-550.
58. Galkina EV, Nazarov PG, Polevschikov AV, Berestovaya LK, Galkin VE, Bychkova NV. Interactions of C-reactive protein and serum amyloid P component with interleukin-8 and their role in regulation of neutrophil functions. Russ J Immunol 2000, 5:363-374.
59. Stibenz D, Gräfe M, Debus N, Hasbach M, Bahr I, Graf K, Fleck E, Thanabalasingam U, Bührer C. Binding of human serum amyloid P componentto L-selectin. Eur J Immunol 2006, 36:446-456. 10.1002/eji.200425360, 16421944.
60. Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D. Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 2008, 83:1323-1333. 10.1189/jlb.1107782, 2659591, 18332234.
61. Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb Protoc 2008, prot4986.
62. Maharjan AS, Pilling D, Gomer RH. Toll-like receptor 2 agonists inhibit human fibrocyte differentiation. Fibr Tiss Rep 2010, 3:23.
63. Delaharpe J, Nathan CF. A semi-automated micro-assay for H2o2 release by human-blood monocytes and mouse peritoneal-macrophages. J Immunol Meth 1985, 78:323-336.
64. Pilling D, Fan T, Huang D, Kaul B, Gomer R. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 2009, 4:e7475. 10.1371/journal.pone.0007475, 2759556, 19834619.
65. Lakatos HF, Burgess HA, Thatcher TH, Redonnet MR, Hernady E, Williams JP, Sime PJ. Oropharyngeal aspiration of a silica suspension produces a superior model of silicosis in the mouse when compared to intratracheal instillation. Exp Lung Res 2006, 32:181-199. 10.1080/01902140600817465, 16908446.
66. Corteling R, Wyss D, Trifilieff A. In vivo models of lung neutrophil activation. Comparison of mice and hamsters. BMC Pharm 2002, 2:1.
67. Sengupta K, Aranda-Espinoza H, Smith L, Janmey P, Hammer D. Spreading of neutrophils: from activation to migration. Biophy J 2006, 91:4638-4648.
68. Kettritz R, Choi M, Rolle S, Wellner M, Luft FC. Integrins and cytokines activate nuclear transcription factor-kappaB in human neutrophils. J Biol Chem 2004, 279:2657-2665.
69. Yong KL, Rowles PM, Patterson KG, Linch DC. Granulocyte-macrophage colony-stimulating factor induces neutrophil adhesion to pulmonary vascular endothelium in vivo: role of beta 2 integrins. Blood 1992, 80:1565-1575.
70. Wittmann S, Rothe G, Schmitz G, Frohlich D. Cytokine upregulation of surface antigens correlates to the priming of the neutrophil oxidative burst response. J Inter Soc Anal Cytol 2004, 57:53-62.
71. Johnson P, Ruffell B. CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets 2009, 8:208-220. 10.2174/187152809788680994, 19601881.
72. Campanero MR, Pulido R, Alonso JL, Pivel JP, Pimentel-Muiños FX, Fresno M, Sánchez-Madrid F. Down-regulation by tumor necrosis factor-alpha of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism. Eur J Immunol 1991, 21:3045-3048. 10.1002/eji.1830211222, 1721026.
73. Dahlgren C, Karlsson A. Respiratory burst in human neutrophils. J Immunol Meth 1999, 232:3-14.
74. Quinn MT, DeLeo FR, Bokoch GM. Neutrophil methods and protocols. Methods Mol Biol 2007, 412:7-8.
75. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992, 148:2207-2216.
76. In V, Haanen C, Steffens-Nakken H, Reutellingsperger C. A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Meth 1995, 184:39-51.
77. Derouet M, Thomas L, Cross A, Moots RJ, Edwards SW. Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J Biol Chem 2004, 279:26915-26921. 10.1074/jbc.M313875200, 15078892.
78. Lai L, Alaverdi N, Maltais L, Morse HC. Mouse cell surface antigens: nomenclature and immunophenotyping. J Immunol 1998, 160:3861-3868.
79. Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol 2007, 178:2000-2007.
80. Birner U, Issekutz TB, Issekutz AC. The role of selectins in VLA-4 and CD18-independent neutrophil migration to joints of rats with adjuvant arthritis. Eur J Immunol 1999, 29:1094-1100. 10.1002/(SICI)1521-4141(199904)29:04<1094::AID-IMMU1094>3.0.CO;2-6, 10229075.
81. Gao JX, Issekutz AC. The beta(1) integrin, very late activation antigen-4 on human neutrophils can contribute to neutrophil migration through connective tissue fibroblast barriers. Immunology 1997, 90:448-454. 10.1111/j.1365-2567.1997.00448.x, 1456599, 9155654.
82. Lundberg S, Lindholm J, Lindbom L, Hellstrom PM, Werr J. Integrin alpha2beta1 regulates neutrophil recruitment and inflammatory activity in experimental colitis in mice. Inflamm Bowel Dis 2006, 12:172-177. 10.1097/01.MIB.0000217765.96604.83, 16534417.
83. Mambole A, Bigot S, Baruch D, Lesavre P, Halbwachs-Mecarelli L. Human neutrophil integrin alpha9beta1: up-regulation by cell activation and synergy with beta2 integrins during adhesion to endothelium under flow. J Leuk Biol 2010, 88:321-327.